IRBs Are Next
Brazil’s CRO Association
The Brazilian association of CROs helped trim the nation’s regulatory pathway. Now it is hoping for similar efficiencies in the ethical review process. more...
The Brazilian association of CROs helped trim the nation’s regulatory pathway. Now it is hoping for similar efficiencies in the ethical review process. more...
Soon, Brazil may no longer have the second-longest trial start-up time on earth. more...
This emerging market just got more competitive with some new, potentially exciting regulatory changes. The first in a series. more...
Icon’s program can move electronic caliper data in heart studies directly into a case report form. more...
Jodie Andrews of ProTrials discusses what matters in selecting a contract research organization. more...
Clinilabs spent a year collaborating with AMPS on a better way to collect and manage ECGs. more...
Mark Goldberg, an architect of technology at a major CRO, discusses the purchase of ClinPhone. An exclusive. more...
The three year old Metrics Champion Consortium, which helped established performance metrics for central labs and ECG, is now turning its focus to imaging and CROs. more...
According to research firm Frost & Sullivan, the global outsourcing market is poised to get far larger, and fast. more...
Target Health has had good news this year, as the company’s Jules Mitchel relates of his EDC and document management systems. more...
The staffing company/CRO combo Trio Clinical Research takes on two equity partners and a C-level acquisition strategist from PRA International. more...
Manhattan-based Clinilabs, started by a sleep researcher, has elected to expand into data management. more...
Josef von Rickenbach discusses electronic data capture, Interactive voice response, and why the industry should not adopt new technologies rapidly. more...
A cancer-oriented CRO says ease of use and the ability to tailor payments were key factors in its choice. more...
In a bold move, the large CRO wants to beef up an already strong technology portfolio. more...
PharmaNet was downgraded from stable to negative by Standard and Poor’s, thanks to $60 million in lost contracts. more...
Organizations
Conferences
Info & Opinion
© 2012 ClinPage. All Rights Reserved.